Nu Skin Enterprises, Inc.
corporate_fare Company Profile
Nu Skin Enterprises, Inc. (NYSE:NUS) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 19 items for NUS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-06, rated 7/10. Across its 19 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for NUS spans 10-Q, 8-K, DEF 14A, 10-K.
Recent high-impact activity:
- Nu Skin 10-Q: Q3 Revenue Falls 14.6% to $311.0M; Nine-Month Loss Reaches $248.7M
- Nu Skin Q3 Revenue $311M, Down 14.6%; Guides Q4 to $310-340M
- Nu Skin Q3 Revenue Falls 14.6% to $311M, Adjusted EPS Drops to $0.10
- Nu Skin Q2 Revenue Plunges 17%, Books $78.9M Goodwill Impairment and $167.5M Tax Charge
- Nu Skin Q2 Revenue Misses, Guides Down Sharply on Customer Exodus
Financial Snapshot
Short Interest & Short Volume
11.33 days to coverFINRA reported short interest of 4,457,541 shares in NUS as of the October 30, 2026 settlement, a 1.8% decrease from the prior period — about 11.3 days to cover at its recent average daily volume. On November 20, 2026, 58.7% of NUS volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for NUS, detected from its recent SEC filings · based on capital-structure filings through 2026-05-29.
Incentive Plan Share Increase Approved · Significant Potential Dilution
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →